Loading…

RadNet, Inc.RDNTCompetitor analysis, valuation and peers

United States · USD·Health Care›Medical/Nursing Services

Largest US operator of outpatient diagnostic imaging centers (MRI, CT, X-ray, mammography), also building AI-enabled imaging software.

Momentum strong 76
Mkt cap
$5.66B
US dollars, full cap
Free float
89%
of shares outstanding
$/day
$59.4M
20-day average traded
Fwd P/E
93.2×
forward earnings
ROIC−WACC
-7.6 pp
WACC 10.3%
Hurdle
+25 pp
Req g minus delivered
Next earnings
104 days
2 Mar 2027
Close · USD$71.82
1D-4.1%
1W-8.0%
1M+3.1%
3M-6.8%
6M+32.5%
YTD+0.7%
1Y-6.8%
ATR %4.2%
Beta1.06
52w lowhigh16.3% off high

What RadNet does

Largest US operator of outpatient diagnostic imaging centers (MRI, CT, X-ray, mammography), also building AI-enabled imaging software.

Bills insurers and Medicare for each scan, under contracts negotiated with health plans, so volumes and reimbursement rates set income. Many centres are run as joint ventures with hospital systems, which feeds referrals. A digital health unit, built through acquisitions of AI software firms, sells software for reading images and detecting disease.

Products and services

  • Outpatient imaging centers
  • AI-enabled imaging analytics (DeepHealth)

Customers

  • Patients (referred by physicians)
  • Health systems/physicians
  • Payers

Where it sits in the supply chain

  • Healthcare
  • Diagnostic imaging services
  • Outpatient imaging center operations

What could go right

  • Outpatient imaging shift from hospitals (lower-cost setting)
  • AI software licensing to third-party imaging providers

What could go wrong

  • Reimbursement rate pressure from payers
  • Capital intensity of imaging equipment

Moat: narrow (scale, installed base, distribution). Largest outpatient imaging network in its markets gives negotiating scale and referral-pattern lock-in.

Headquarters: Los Angeles, California, USA · Founded: 1981 · Employees: 8,844

Named competitors

  • Hospital-owned imaging departments private or unlisted
  • Regional independent imaging center operators private or unlisted

RadNet at a glance

Size RadNet (RDNT) is a United States Health Care company (Medical/Nursing Services) with a market value of $5.66B, the 1091st largest of 3,085 United States companies the cockpit tracks. Shares closed at $71.82 on 18 Nov 2026.

Performance Over six months the shares gained 32.5%, against +16.6% for the median peer and -2.2% for the United States market (cap-weighted) — 7th highest of 20 in its peer set.

Growth Revenue grew 21.1% over the last twelve months (peer median +11.7%); the operating margin is 4.7% (peer median 10.7%).

Valuation It trades at 93.2× forward earnings against a peer median of 20.7× (2nd most expensive of 19).

Price implies For today's price to make sense, revenue must grow about 39% a year for seven years (Req g). Recent delivered growth is +14%, so the hurdle is +25 pp: the price needs faster growth than the company has been delivering — of companies that just grew 25–50% a year, 93.8% slowed down over the next four years.

Capital Return on invested capital runs 7.6 points below its cost of capital (10.3% WACC).

Short interest Short interest is 11.3% of the free float (30 Oct 2026).

Next results Next results expected around 2 Mar 2027 (exchange calendar; dates can move).

Relative performance

10012014021 May 202621 Aug 202618 Nov 2026RDNT 132Peer median 118
Six months, rebased to 100: RadNet against the median of its 20 peers (local-currency closes).

RadNet financials

Reported figures in USD; fiscal year ends 2025-12-31. TTM = trailing twelve months.
TTMFY2025FY2024FY2023FY2022
Revenue$2.38B$2.04B$1.83B$1.62B$1.43B
Revenue growth—+12%+13%+13%—
Gross profit$112M$90.8M$111M$93.0M$49.8M
EBITDA$290M$243M$249M$282M$235M
Net income-$22.4M-$18.7M$2.79M$3.04M$10.7M
Free cash flow$115M$85.6M$45.0M$44.3M$27.0M
Capital expenditure$233M$213M$188M$177M$119M
Total debt$2.17B$1.86B$1.73B$1.49B$1.51B

Quarterly statements and history in the cockpit →

RadNet competitor charts

The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.

Performance: 6-month against 1-month return

-25%0%+25%+50%+75%-40%-20%0%+20%CONLFSTOPCHSHLBLLNHIMSMCOV-BLALPATHLABACHCDVAENSGFME002044300015EHCMDAVAHBTSGRDNT6-month return →1-month return →
Up and to the right = strong over both horizons. RadNet is the large dot.

Fundamentals: revenue growth against valuation

0%+20%+40%+60%50×100×CONLFSTOPCHSHLBLLNMCOV-BLALPATHLABACHCDVAENSG002044300015AVAHBTSGRDNTRevenue growth (TTM) →Forward P/E →
Further right = faster growth; higher = more expensive. The dashed lines are the peer medians. RadNet is the large dot.

Capital: growth delivered against growth the price implies

0%+20%+40%+60%0%25%50%75%CONLFSTOPCHSHL3774BLLNMCOV-BLALPATHLABDVAENSGFMEBTSGRDNTGrowth delivered (Del g) →Growth the price implies (Req g, 7 yrs) →
Above the diagonal = the price needs more growth than the company has been delivering; below = the price already allows for a slowdown. RadNet is the large dot.

RadNet competitors and peer comparison

How RadNet compares with its peers

Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.

RadNet against its 20 peers (data as of 18 Nov 2026)
MeasureRDNTPeer medianRank in peer set
1-month return+3.1%+5.3%10th lowest of 21
6-month return+32.5%+16.6%7th highest of 20
Distance from 52-week high-16.3%-12.9%8th lowest of 21
Revenue growth (TTM)+21.1%+11.7%6th highest of 21
Operating margin4.7%10.7%3rd lowest of 21
Forward P/E93.2×20.7×2nd most expensive of 19
Growth the price implies (Req g, 7 yrs)38.8%8.4%2nd most demanding of 19
Growth delivered (Del g)+13.7%+12.5%7th highest of 19
Hurdle (Req g minus delivered)+25.0 pp-2.1 ppmost demanding of 19
ROIC minus cost of capital-7.6 pp+3.4 pp2nd lowest of 21
EV / EBITDA25.5×12.0×4th most expensive of 16
Net debt / EBITDA4.9×2.5×2nd most indebted of 19

Peer table

Peer set: Industry: the same industry and sector in any market, nearest in size
CompanyMarketMarket cap6M returnRevenue growthOp. marginForward P/EReq gDelivered g
RadNet RDNTUnited States$5.66B+32%+21%5%93.2×38.8%+13.7%
Concentra Group Holdings Parent CONUnited States$5.31B+65%+12%17%22.3×3.6%+7.9%
Lifestance Health LFSTUnited States$5.24B+79%+23%6%51.8×33.4%+30.4%
Option Care Health OPCHUnited States$4.75B+43%+4%6%15.7×2.0%+13.2%
Sonic Healthcare SHL.AXAustralia$6.87B+6%+14%9%17.4×9.1%+3.5%
Fameglow 3774.HKHong Kong$4.54Bn/a+36%11%n/a57.4%+48.4%
BillionToOne BLLNUnited States$4.37B+7%+72%10%115.3×22.8%+71.9%
Hims & Hers Health HIMSUnited States$4.00B-26%+30%-1%n/an/an/a
Medicover MCOV-B.STSweden$3.87B+21%+3%7%36.1×19.6%+20.2%
Dr. Lal PathLabs LALPATHLAB.NSIndia$3.53B+15%+17%24%50.5×32.3%+11.8%
Acadia Healthcare ACHCUnited States$3.49B+56%+4%10%18.6×n/an/a
DaVita DVAUnited States$10.2B-18%+6%15%10.1×-2.5%+3.4%
Ensign ENSGUnited States$10.7B+3%+17%9%21.3×12.7%+16.5%
Fresenius Medical Care FME.DEGermany$11.2B+3%-1%11%9.5×-4.8%+1.9%
Meinian Onehealth Healthcare 002044.SZChina$2.60B-27%-4%9%49.6×4.2%+5.7%
Aier Eye Hospital 300015.SZChina$12.5B-14%+5%21%30.1×11.8%+13.4%
Encompass Health EHCUnited States$13.2B+27%+9%18%20.1×5.7%+5.0%
Pediatrix Medical MDUnited States$2.41B+37%+2%12%12.4×-4.4%+2.0%
Aveanna Healthcare AVAHUnited States$2.37B+41%+17%12%12.2×7.7%+10.2%
BrightSpring Health Services BTSGUnited States$13.6B+17%+23%4%28.8×24.9%+18.3%
Addus HomeCare ADUSUnited States$2.25B+29%+12%11%16.2×4.0%+13.2%

Questions

Who are RadNet's main competitors?
Named competitors: Hospital-owned imaging departments (private or unlisted), Regional independent imaging center operators (private or unlisted). The cockpit's measured peer set (industry) also includes Concentra Group Holdings Parent (CON), Lifestance Health (LFST), Option Care Health (OPCH), Sonic Healthcare (SHL.AX), Fameglow (3774.HK), BillionToOne (BLLN).
Is RadNet expensive compared with its peers?
On forward p/e it trades at 93.2× against a peer median of 20.7×, 2nd most expensive of 19 in its peer set. For today's price to make sense, revenue must grow about 39% a year for seven years (Req g). Recent delivered growth is +14%, so the hurdle is +25 pp: the price needs faster growth than the company has been delivering — of companies that just grew 25–50% a year, 93.8% slowed down over the next four years.
How has RadNet stock performed?
Over six months to 18 Nov 2026 the shares returned +32.5% against +16.6% for the median peer; over one year -6.8%.

How these numbers are made. Returns are close-to-close in local currency. Revenue growth and margins are trailing twelve months. Req g is the revenue growth that today's enterprise value requires for seven years at the company's own cost of capital; Delivered g is what it actually grew; the gap is the hurdle (honest precision about ±8 points, so read the ranking more than the decimal). No fair values, price targets or analyst ratings are shown, by design. Method and validation.